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Abstract 
Transforming growth factor beta-1 (TGF- β1) is the most important 
inhibitory cytokine during the hepatic regeneration process. Diltiazem is a L-
type calcium channel blocker that has inhibitory effect on TGF- β1. The aim 
of the present study was to determine the effect of diltiazem on hepatic 
regeneration. Sixty female Wistar Albino rats were used. Three groups were 
created; the control, low dose diltiazem and high dose diltiazem groups, each 
consisting of 20 rats. After partial liver resection (70% hepatectomy), saline 
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was introduced to control group, 5 mg/kg diltiazem was introduced to low 
dose group and 15 mg/kg diltiazem to high dose group intraperitoneally. Ten 
rats in each group were sacrificed on the first postoperative day and the 
remaining rats on the fifth day. Liver weight, mitotic rate and the Ki-67 ratio 
were measured for determining hepatic regeneration. Liver regeneration rate 
on the fifth postoperative day was significantly higher both in the low dose 
and high dose diltiazem groups than the control group (Low diltiazem vs 
control: P<0.001; High diltiazem vs control: P<0.001). No significant 
difference was found between the groups regarding the number of mitoses on 
the first and fifth days following partial hepatectomy (P>0.05). The Ki-67 
ratio on the first postoperative day was significantly higher both in the low 
dose and high dose diltiazem groups than the control group (Low diltiazem 
vs control: P<0.001; High diltiazem vs control: P<0.001). Diltiazem increases 
liver regeneration by inhibiting TGF-β1.
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Introduction 
 One of the most important limitations in hepatic surgery is the 
functional capacity of the remaining liver tissue following major hepatic 
resection. Many studies have been conducted on the complex regeneration 
process of the liver, which is affected by various different cytokines and 
hormones (Diehl & Rai,1996, Bucher,1991, Noguchi,1991, LaBrecque,1994). 
During the regeneration process, some cytokines act to increase the 
regeneration, whereas the other some have inhibitory effects.  A number of 
model have been proposed for the study of liver regeneration. The most 
common studied model is partial hepatectomy ( Mao SA,2014).  
 It has been previously demonstrated that TGF- β1, which source has 
been proven to be the spleen, is the most important inhibitory cytokine during 
the hepatic regeneration process ( Akahoshi, Hashizume, Tanoue, et al.2002, 
Tomikawa, Hashizume, Highashi et al.1996, Zhong, Tsukada, Rehman, et 
al.2010, Houck & Michalopoulos 1989, Ueda, Yamanoi, Hishikawa, et 
al.2003, Friedman, Flier, Underhill 1993 ).  It is also known that splenectomies 
increase hepatic regeneration (Perez,1983, . Perez & Romero,1958). 
 Diltiazem is a L-type calcium channel blocker, which is used in the 
treatment of hypertension and arrhythmia (Kayaalp,1990). Several studies 
have shown that diltiazem prevents renal interstitial fibrosis and peritoneal 
fibrosis by inhibition of TGF-β1(Kesgin, Oktay, Yavascaoglu, Simsek et al, 
2002). It has been also demonstrated that diltiazem causes TGF-β1 inhibition 
in liver cell cultures ( Crenesse, Tornieri, Laurens, et al,2002).   
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 Although diltiazem causes TGF-β1 inhibition in various tissues, its 
effect on hepatic regeneration is still unknown. The aim of the present study 
was to determine the effect of diltiazem on hepatic regeneration. 
 
Material and Methods 
After approval of the ethical committee of ****** University, the 
study was conducted in November 2012 in the Experimental Animal Research 
Laboratory at ***** University’s Medical Faculty. Sixty 8-10-week-old 
Wistar Albino type female rats, weighting 200-250 were used for the study.  
 The rats were kept at 23 °C, with 50% humidity, and a 12 h light and 
dark cycle for 2 weeks, with free access to water and food. Regular 
replacement of cage and clean bedding before the experiments were provided. 
Three groups were formed, including 20 rats in each group: 
Control group (Saline (0.09% NaCl) introduced by intraperitoneal 
way after 70% partial hepatectomy)  
Low dose diltiazem group (5 mg/kg introduced by intraperitoneal 
way after 70% partial hepatectomy)  
High dose diltiazem group (15 mg/kg introduced by intraperitoneal 
way after 70% partial hepatectomy)  
 As the regenerative responses change daily, the operations were 
conducted in the first half of the day. The rats to be operated were on fasting 
one night prior. For anesthetic purposes, 80/12 mg/kg ketamine HCl (Ketalar, 
Eczacıbaşı) / xylene HCL (Rompun, Bayer) were intramuscularly 
administered. After controlling for sufficient anesthesia depth by determining 
the loss of cornea and gag reflexes, the rats’ abdomens were shaved and they 
were attached to the operation board by their four extremities. The abdomen 
was cleaned with 10% povidone iodine and an abdominal laparotomy was 
performed with a midline incision of 2.5 cm. The pedicles of the left lateral 
and median lobes were ligated with 4/0 silk. A approximately 70% partial 
hepatectomy was performed by resection of median and left lobes of the liver, 
as defined by Higgins and Anderson (Higgins & Anderson.,1931). The 
removed liver tissue was weighed and recorded for each animal. After this 
stage, before closure of the abdomen, Saline solution (0.09% NaCl) was given 
to the control group, 5 mg/kg diltiazem (Diltizem–L® enjektabl 25 mg, 
Mustafa Nevzat, Istanbul, Turkey) was administered intraperitoneally in the 
low dose diltiazem group, and 15 mg/kg diltiazem in the high dose diltiazem 
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The weight of regenerated liver 
The wet weight of the removed left and median liver lobes were 
determined after partial hepatectomy (RA) by assuming that 70% of whole 
weight of the liver was resected, and total weight of liver before resection was 
calculated (TA=RA/0.7). Total weight of liver on the day of sacrificing (SA) 
was divided by the calculated assumed weight before resection (TA) and the 
amount of resection was calculated with the Kwon formula (SA/TA x 100)( 
Kwon, Uetsuji, Yamamura et al, 1990). From another perspective, this 
formula provides information about the weight proportion reached on the day 
of sacrifice compared to the weight before resection.    
 
Histological and immunological assessment 
Histological and immunological assessments were performed in the 
Pathology Laboratories of ******** Teaching and Research Hospital. The 
obtained tissue samples were fixed in buffer formalin (10%). Five µm sections 
were taken from the prepared paraffin blocks. The mitoses were counted under 
10x large magnification field stained with hematoxyline & eosin (Olympus, C 
x 31).The proportions were given as percentage(Selzner & Clavien, 2000).  
To determine Ki-67 expression, 5µm thick sections were taken to lame 
with ‘Poly- L-Lysine’. Ki-67 (SP6) (Neomarkers, USA) was administered 
using the immunohistochemical staining procedure with ready-for-use rabbit 
monoclonal antibody. The sections that were left at 37ºC for one night were 
held at 60 ºC for 60 minutes on the next day. For deparafinization, they were 
held in xylazine for 5 minutes, repeating three times, and in alcohol for 5 
minutes, repeating three times, as well (first absolute, then 96%). To rehydrate, 
they were held in distilled water for 5 minutes, repeating three times. For 
antigen retrieval, pressured vapor was administered for 5 minutes to thelame, 
which were placed into EDTA buffer (pH:8) and diluted at a ratio of 1/10 with 
distilled water. The sections, which were cooled at room temperature, were 
washed with distilled water. To inhibit endogenous peroxidase activity, they 
were incubated in 3% hydrogen peroxide for 20 minutes. Then, the sections 
were washed with distilled water for 5 minutes, repeating three times. They 
were washed with PBS (phosphate buffer saline) for 5 minutes, repeating three 
times, as well. Furthermore, they were washed in blocking solution for 5 
minutes. They were incubated with Ki-67 monoclonal antibody at room 
temperature for 60 minutes. After washing with PBS solution for 5 minutes, 
repeating three times, the routine staining procedure with HRP AEC 
(Horseradish peroxidase - 3-amino-9-ethyl-carbazole) method was completed 
( Wintzer, Zipfel, Mönting, et al. 1991). While evaluating the Ki-67 staining 
pattern, the nuclear staining in 1000 cells were counted. The proportion of the 
positively stained nucleuses was given as percentage.   
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Statistical Analysis 
The data were analyzed using SPSS for Windows 11.5 package 
program. The distribution of continuous variables was determined to be 
normal or not with the Shapiro-Wilk test. The descriptive statistics were 
demonstrated as median (minimum-maximum). The significance of the 
difference between groups in terms of median values was evaluated with the 
Kruskal-Wallis test. When the results of the Kruskal-Wallis test statistics 
were significant and non-parametric, the multiple comparison test was used 
to determine the factors causing the difference. Values of P<0.05 were 
accepted as statistically significant. However, Bonferroni’s correction was 
used to control for Type I errors in all possible multiple comparisons 




No significant difference was found between the groups on the first 
postoperative day according to the weight measurements of the liver remnant 
tissues (P>0.05). However, the liver regeneration rate on the fifth 
postoperative day was significantly higher both in the low dose and high dose 
diltiazem groups than the control group (Low diltiazem vs control: P<0.001; 
High diltiazem vs control: P<0.001). The difference between high dose and 
low dose diltiazem groups was not significant (P>0.05). 
Table 1. Regeneration Rates of Groups at the first and 5th days after partial hepatectomy 
Groups First day (n=10) 
(%, min-max) 
5th day (n=10) 
(%, min-max) 
Control                 35.85 (24.1-54.7) 42.7 (38.9-57)b,c 
Low Dose   45.35 (34.3-55.2) 66.45(41.4-97.6)b 
High Dose  50.3 (43.2-60.2) 97.9 (62.1-125.4)c 
Pvaluea >0.05 <0,001 
a P<0.025 was considered statistically significant according to the Bonferroni Correction 
b Control group vs Low dose Diltiazem group (P<0.001)  
c Control group vs High dose Diltiazem group (P<0.001) 
 
Mitosis 
No significant difference was found between the groups regarding the 
number of mitoses on the first and fifth days following partial hepatectomy 
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Table 2.Number of Mitotic Rates of Groups in the 1th and 5th days after partial 
hepatectomy 
Groups  1th day (n=10) 5th day (n=10) 
Control         [(number,  median (min-max)] 1 (0-2) 0 (0-1)b 
Low Dose      [(number,  median (min-max)] 3 (0-12) 0.5(0-7)c 
High Dose     [(number, median  (min-max)] 1 (0-2) 0.5 (0-2)b,c 
p-valuea >0.05 >0.05 
a According to Bonferroni correction p<0,025 was accepted statistically significant.  
b The difference between Control and low dose group was not statistically significant. (p>0.05) 
c The difference between control and high dose group was not statistically significant (p>0,05) 
 
Ki-67 ratio 
The Ki-67 ratio on the first postoperative day was significantly higher 
both in the low dose and high dose diltiazem groups than the control group 
(Low diltiazem vs control: P<0.001; High diltiazem vs control: P<0.001). 
However, no significant difference was found between the groups on the fifth 
postoperative day (P>0.05), (Table 3). The Ki-67 did not significantly alter 
in the control group between the first and fifth postoperative days (P>0.05). 
On the other hand, the Ki-67 ratio significantly decreased on the fifth 
postoperative day both in the Low dose (P=0.008) and High dose (P=0.002) 
diltiazem groups when compared with the first postoperative day. 
Table 3. Ki-67 ratio of Groups in the 1th and 5th days after partial hepatectomy 
Groups 1th day (n=10) 5th day (n=10) 
control       [%,  median (min-max)] 0.5 (0-5)b,c 2 (1-8) 
Low Dose   [%, median (min-max)] 27.5(14-43)b 2.5(0-26) 
High Dose  [%, median (min-max)] 9 (6-28)c 0.5 (0-4) 
p-valuea <0,001 >0.05 
a According to Bonferroni correction p<0,025 was accepted statistically significant  
b The difference between Control and low dose group was not statistically significant. (p>0.05) 
c The difference between control and high dose group was not statistically significant (p>0,05) 
 
Discussion 
The liver is the only organ in humans and animals that has the capacity 
to grow and regenerate (Akcan, Kucuk, Ok et al.2006). Hepatic resections are 
performed due to many benign and malignant causes. Although individuals 
with healthy liver tissue have the ability to tolerate hepatectomy up to 80%, 
functional insufficiency may develop sometimes until the remaining liver 
tissue regenerates (Makuuchi, Takayasu, Takuma,1984). 
Many cytokines play a role during the regeneration process that begins 
with lipopolysaccharides and cytokines from intestinal origins. Tumor 
necrosis factor- alpha (TNF-α) and interleukin-6 (IL-6) induce hepatocytes 
from G0 phase to G1 phase. On the other hand, hepatic growth factor (HGF) 
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and epidermal growth factor (EGF) stimulate the progression of the cell cycle 
and regeneration(Roy-Chowdur,2006). The most important inhibitor cytokine 
for regeneration is TGF-β1(Zhong, Tsukada, Rehman et al, 2010, 
Tao,Wang,Chen et al, 2017 Houck&,Michalopoulos, 1989, Ueda, Yamanoi, 
Hishikawa et.al, 2003).  Previous studies have shown that the spleen-derived 
TGF-β1 plays inhibitory role in hepatic regeneration and induces fibrosis 
(Akahoshi, Hashizume, Tanoue, et al.2002, Zhong, Tsukada, Rehman, et al. 
2010 ). On the other hand, several studies have demonstrated that TGF-β1 
monoclonal antibodies increase hepatic regeneration through TGF-β1 
blockage (Akcan, Kucuk, Ok et al. 2006, Makuuchi, Takayasu, Takuma 
1984). TGF-β1 shows this effect by direct inhibition of cell proliferation and 
induction of apoptosis (Zhong, Tsukada, Rehman, Parsons CJ, et al,2010, 
Ueda, Yamanoi, Hishikawa, et al.2003). 
Nakamura et al. demonstrated in a cirrhotic rat model that TGF-β1 
inhibition prevents liver fibrosis and increases the hepatocyte regeneration. 
Further, Akahoshi et al (Akahoshi, Hashizume, Tanoue, et al. 2002). showed 
the spleen as a source of TGF-β1. Ueda et al. proved the same effect of spleen-
derived TGF-β1.   
Diltiazem, which is a L-type calcium channel blocker, is a widely used 
in clinical practice due to its anti-hypertensive and anti-arrhythmic properties. 
It does not produce hypotension in either normotensive individuals or rats; 
furthermore, its inhibitory effect on TGF-β1 is higher than other calcium 
channel blockers ( Kayaalp O. 1990, Wang, Tao, Yuan et al. 2010, Fang, Yen, 
Chen, et al. 2006, Cuschieri, Gourlay, Garcia, et al. 2002 ).  It has been 
demonstrated that diltiazem has various effects in many tissues by inhibiting 
TGF-β1 at the level of receptor and intracellular conductive pathways (Kesgin, 
Oktay, Yavascaoglu, et al..2002, Wang, Tao, Yuan, et. Al. 2010) . Moreover, 
it prevents ischemic-reperfusion injury related apoptosis by inhibition of the 
TGF-β1-jnk pathway in hepatocyte cell cultures (Crenesse, Tornieri, Laurens, 
et.al,2002) . 
It has been determined that best liver regeneration response in rats is 
following 70% partial hepatectomy (Higgins & Anderson, 1931). Active cell 
replication starts within 24 hours following partial hepatectomy and it 
continues until reaching the initial weight of the organ. A significant amount 
of regeneration occurs within the first ten days and this process is completed 
in 4-5 weeks( Michalopoulos& DeFrances,1997) . However, in humans, the 
liver reaches its previous size in 3-6 months. In the presence of cirrhosis, this 
period may increase up to 9-15 months (Nagasue, Yukaya, Ogawa, et.al. 
1987). 
Ki-67 is a nuclear protein that is used to measure the tissue 
proliferation index, as it is directly proportional to cell proliferation at a high 
rate. It is correlated with ribosomal RNA transcription. During the interphase, 
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it could be observed in the cell nucleus at a high rate. Although it is most 
commonly observed during the interphase, it can be seen in all active phases 
of the cell cycle. However, it is not present in cells during the resting phase 
(G0) (Gerdes, Lemke, Barsch, et. al, 1984) In the present study, the Ki-67 ratio 
was to be found highest in the low dose diltiazem group. Additionally, the Ki-
67 ratio also was higher in the high dose diltiazem group than the control 
group. 
It has been previously shown that most of the DNA synthesis was done 
by hepatocytes on the first day following partial hepatectomy. Similarly, when 
we compared with the control group, the Ki-67 ratios both in the low dose and 
high dose diltiazem groups were significantly higher on the first day than the 
fifth day.  The DNA synthesis occurs in biliary ductal cells and Kupffer cells 
at the 36th hour (Michalopoulos & DeFrances, 1997, Perek & Kapan, 2000 ) . 
In the present study, DNA synthesis decreased in all three groups after the 
second day.  
In the present study, when all three groups were evaluated in terms of 
the number of mitosis, no significant difference was found. However, -
although statistically not significant- mitosis was higher observed in the low 
dose diltiazem group on the first day than the other groups. It is known that 
mitosis in rats is set to zero on the 10th day following partial hepatectomy ( 
Michalopoulos & DeFrances, 1997). Again depending on the dose, most of 
the mitosis in the liver is completed before the first day following partial 
hepatectomy; thus, no difference was observed between three groups on the 
first and the 5th days, in terms of the number of mitoses. 
In conclusion, diltiazem increases hepatic regeneration by inhibition 
of TGF-β1 in a partially hepatectomized rat model. However, more 
experimental and clinical studies are required for its routine use in clinical 
practice for humans. 
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